Skip to main content
. 2011 Nov 17;21(5):1124–1137. doi: 10.1093/hmg/ddr541

Figure 4.

Figure 4.

Bezafibrate attenuates astrogliosis in R6/2 brains. Photomicrographs showing GFAP immunoreactivity in the striatum of wild-type and R6/2 mice with or without bezafibrate treatment. GFAP-labeled hypertrophied astrocytes (inset) are evident in the striatum of R6/2 mice. Astrogliosis in the HD striatum is reduced by bezafibrate treatment.